Telcare’s Qualcomm-Based CDMA Glucose Meter Certified by Verizon and Unveiled at CES First mHealth device for diabetes to operate on the Verizon network 2013 International CES Business Wire LAS VEGAS -- January 8, 2013 Telcare’s next-generation wireless blood glucose meter – the Telcare BGM® has now been certified to operate on Verizon’s nationwide cellular network. The product was developed in collaboration with both Verizon and Qualcomm, Inc., and is the first medical device to utilize Qualcomm’s new Internet of Everything module. Telcare’s product is the first technology to make CDMA connectivity affordable for consumer-focused medical devices. The product will be exhibited in Telcare’s booth, located inside the Qualcomm Life Pavilion #26715 at the 2013 Consumer Electronics Show. The Telcare product will operate with both Telcare’s FDA-cleared diabetes management portal and with other soon-to-be released mHealth care management platforms. By integrating Telcare’s FDA-cleared blood glucose meter and cloud server to the Verizon network, people with diabetes, their families, and their health professionals will now be able to integrate real-time measurement of blood glucose levels with other physiologic parameters, such as weight and blood pressure. “Telcare is excited to establish this collaboration as it will enable us to better support Americans with diabetes, their loved ones, and their medical caregivers. Moreover, the outstanding cellular coverage afforded nationwide by Verizon wireless will be particularly valuable in continuously connecting people with diabetes to their care system,” said Jonathan C. Javitt, M.D., M.P.H., Telcare’s CEO and co-founder. Diabetes mellitus affects 32 million Americans and the Centers for Disease Control (CDC) estimates that one in three Americans born after 2000 will have the condition. Although the complications of diabetes can be prevented through daily monitoring and control of blood sugar, diabetes today accounts for one in ten healthcare dollars spent in the U.S. and results in needless strokes, heart attacks, amputations and cases of blindness. About Telcare, Inc.: Telcare, Inc. uses cellular technology and social networking to bridge the last mile between patients with diabetes, their caregivers, and their families in order to transform the care of chronic illness. The Company’s first product, a wireless Blood Glucose Monitoring System, was launched in February 2012. Telcare has been awarded two First Place E-Tech awards by CTIA, been named the MEDTEC startup of the year, been awarded the Triple Tree Award at the Wireless Life Sciences Alliance and been awarded the 2012 Edison Gold Award. Telcare’s products have been featured in the Wall Street Journal, the New York Times, Forbes, Fox News, and numerous other media sources. Telcare is funded by Sequoia Capital (Menlo Park, CA), the Qualcomm Life Fund (San Diego, CA), and private investors. The Company was founded in 2009 by Jonathan C. Javitt, M.D., M.P.H., John R. Dwyer, Jr., and David Bjork. For more information, visit www.telcare.com. Telcare BGM is a registered trademark of Telcare, Inc. Contact: Telcare, Inc. Jennifer Kuesel, 240-369-6003 EXT 116 Email: email@example.com
Glaxo to Pay $488.7 Million Fine to End China Corruption Probe
Telcare’s Qualcomm-Based CDMA Glucose Meter Certified by Verizon and Unveiled at CES
Press spacebar to pause and continue. Press esc to stop.